Pacific Biosciences Of California (PACB) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Pacific Biosciences Of California (PACB) over the last 10 years, with Q3 2025 value amounting to -$0.13.
- Pacific Biosciences Of California's EPS (Weighted Average and Diluted) rose 4090.91% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.15, marking a year-over-year decrease of 4726.03%. This contributed to the annual value of -$1.07 for FY2024, which is 1119.79% up from last year.
- As of Q3 2025, Pacific Biosciences Of California's EPS (Weighted Average and Diluted) stood at -$0.13, which was up 4090.91% from -$0.14 recorded in Q2 2025.
- In the past 5 years, Pacific Biosciences Of California's EPS (Weighted Average and Diluted) registered a high of $0.08 during Q3 2021, and its lowest value of -$1.44 during Q1 2025.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.34, with a median of -$0.31 in 2023.
- Examining YoY changes over the last 5 years, Pacific Biosciences Of California's EPS (Weighted Average and Diluted) showed a top increase of 15714.29% in 2021 and a maximum decrease of 460000.0% in 2021.
- Quarter analysis of 5 years shows Pacific Biosciences Of California's EPS (Weighted Average and Diluted) stood at -$0.33 in 2021, then dropped by 12.12% to -$0.37 in 2022, then rose by 16.22% to -$0.31 in 2023, then skyrocketed by 102.65% to $0.01 in 2024, then tumbled by 1681.09% to -$0.13 in 2025.
- Its last three reported values are -$0.13 in Q3 2025, -$0.14 for Q2 2025, and -$1.44 during Q1 2025.